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Objective. To study prospectively aneurysm formation, need of surgery, incidence of rupture and mortality in patients
with conservatively treated acute type B aortic dissection.
Methods. All patients referred to us with acute type B dissection between January 1990 and December 2001 were
candidates for this prospective treatment and follow-up study. Patients deemed not to be in need of acute surgical
repair were included after aggressive antihypertensive treatment. The follow-up protocol included close blood pressure
control, clinic visits with physical examination, chest x-ray and spiral CT or MRI at 3 and 6 months and annually
thereafter.
Results. Sixty-six patients were followed for a mean of 79 months (range 22e179). The actuarial survival rate was 82%
at 5 years and 69% at 10 years. Eighty-five percent remained free from dissection-related death at 5 years and 82% at
10 years. Ten patients (15%) developed aneurysm (>6 cm) of the dissected aorta. Three of these 10 patients died from
aortic rupture and 2 underwent elective surgical repair. Of the 56 patients without aneurysm, one died from rupture and
one died suddenly for causes unknown. One patient was treated with endovascular stent-graft. Five patients sustained
a new type A aortic dissection which in all but one were fatal. In 26 patients the initial dissection was categorized as
intramural hematoma. Twelve of these patients had, in addition to the hematoma, areas with localized dissection/ulcer-
like projection. The latter was found to be a predictor of aortic event (dissection-related death, rupture, new type A aortic
dissection, aneurysm formation) during follow-up, as was an initial diameter of >4.0 cm at first CT-scan during the
acute event.
Conclusions. Conservatively treated acute type B dissection has a low incidence of aneurysm formation and rupture dur-
ing the chronic phase. These results must be matched or improved upon before endovascular stent-grafting or early aortic
surgical repair can be regarded as the primary treatment of choice.
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Patients referred for acute type B aortic dissection and
deemed not to be in need of acute aortic repair were
included in this prospective study initiated in 1990.
The patients were managed during the acute phase
according to the non-surgical approach based on
aggressive antihypertensive treatment described by
Wheat and coworkers already in 1965.1 The aim of
our study was to follow these non-operated patients
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sive medication and to investigate aneurysm forma-
tion, need of surgery, incidence of rupture and
mortality during the chronic phase.
Retrospective studies have reported aneurysm
development, rupture and need of surgical repair in
more than a third of patients with chronic type B
aortic dissection2,3 as well as a poor long term prog-
nosis.4,5 Endovascular stent-graft placement has
evolved over the last decade and has been used as
an alternative or in addition to surgery for the treat-
ment of complications of acute type B dissection.6,7
It has even been suggested to use stentgraft placement
for all patients with acute type B aortic dissection. By
closing the false lumen the stent-graft is thought to
promote healing and prevent aneurysm formation.8e10rved.
350 A. Winnerkvist et al.In some studies also acute surgical repair11,12 has been
claimed to improve long term results.
Materials and Methods
Patients
Our hospital is a regional referral center for patients
with aortic disease in the Stockholm area of presently
1.87 million inhabitants. Between January 1990 and
December 2001, 84 patients were referred to us be-
cause of type B aortic dissection. Fourteen patients
were not included because the dissection was con-
sidered chronic. Two patients with acute type B dis-
section underwent acute surgical repair and two
patients died during the acute care. Sixty-six patients
deemed not to be in need of acute surgical repair were
therefore included in the study. There were 50 males
(76%) and 16 females (24%). The study was designed
as a prospective follow-up and not intended to inves-
tigate outcome during the acute phase of the dissec-
tion. The mean age was 62 years for both sexes with
a range of 33e80 years at the time of dissection. For
previous medical history see Table 1. The closing
date for follow-up was December 31st 2004. The study
was approved by the Ethics Committee at the Karolin-
ska University Hospital.
Acute management
During the acute phase, hypertension is treated ag-
gressively to bring down the systolic blood pressure
to <120 mmHg. b-adrenergic antagonists are used
Table 1. Previous medical history in 66 patients included in a
prospective follow-up study after conservatively managed acute
type B aortic dissection
No. % Mean Range
Gender
Male 50 76
Female 16 24
Age at acute dissection (y) 62 33e80
History of:
Hypertension 36 55
Smoking 36 55
Known aortic-aneurysm 6 9
Abdominal aortic
aneurysm repair
4 6
Stroke 5 8
Myocardial infarction 4 6
Angina pectoris 4 6
Coronary artery
bypass surgery
2 3
Renal dysfunction 5 8
Diabetes Mellitus 2 3
Peripheral vascular disease 3 5Eur J Vasc Endovasc Surg Vol 32, October 2006whenever tolerated to decrease the LV-ejection force
(dP/dT). When the blood pressure is stabilized and
the patient is on oral antihypertensive treatment he
or she is transferred to a regular floor bed, usually
after 3e4 days. Long term antihypertensive treatment
is initiated in all patients. Uncomplicated cases, where
the blood pressure is well controlled, are discharged
after 10e14 days and after a control CT-scan. The re-
ferring hospital or the patient’s primary care physician
is requested to continue close blood pressure control.
Follow-up
The patients visited our outpatient clinic 3e4 weeks
after the acute episode, allowing us to inform about
the disease and to discuss prognosis and continued
care. The patients were studied for new morbidity
and increase in aortic size with physical exams, chest
x-ray and CT-scan or MRI, 3 months and 9 months af-
ter the acute phase and yearly thereafter or at shorter
intervals if clinically indicated. Surgery for chronic
type B dissection was considered if the patient devel-
oped an aneurysm of more than 6 cm in diameter, if
the dissected aorta expanded rapidly, or if the patient
reported pain or other symptoms that might be re-
lated to the diseased aorta. End points for the study
were death, surgery of the dissected aorta and loss
to follow-up due to relocation.
Any occurrence of dissection-related death, rup-
ture, new type A aortic dissection, or aneurysm forma-
tion in the dissected aorta (>6.0 cm in diameter) was
defined as an ‘‘aortic event’’ for statistical comparison.
During the progress of the study we could on CT-
scan identify three subtypes of dissection: 1. Classical
dissection with a ‘‘double barrel’’ appearance i.e. a
dissection flap and flow in the false lumen with or
without partial thrombosis; 2. ‘‘Pure’’ intramural he-
matoma without blood flow in the false lumen and
with no detectable intimal tear; 3. Intramural hema-
toma in the major part of the affected aorta but, in ad-
dition, areas of localized dissection or contrast filled
pouches in the aortic wall, sometimes referred to as
ulcer-like projections.
Statistical methods
Patient survival, freedom from dissection-related
death and freedom from aortic event were analyzed
using the product limit method of Kaplan and
Meier.13
To seek possible predictors of aortic event, 12 inde-
pendent variables were defined and analyzed with
univariate analysis using the Mantel-Haenszel
351Follow-up of Type B Aortic Dissectionlogrank test. A P value 0.05 was considered statisti-
cally significant. Predictors of aortic event were then
identified by multivariate analysis using Cox’s pro-
portional hazard model14 including variables with a
P value 0.20 at univariate analysis.
Demographic and dimensional data were analyzed
by the ManneWhitney nonparametric U-test or non-
parametric ANOVA. A P value 0.05 was considered
statistically significant. Data are presented SD when
applicable. The observed survival for all Swedish inhab-
itants of the same sex and age as the patients and who
were alive at the time of the acute dissection was used
for a visual comparison to the patients. A composite sur-
vival curve was constructed for the comparison group in
collaboration with Statistics Sweden (the Swedish popu-
lation bureau)15 with survival percentages plotted for
each year. Errors of sampling do not apply since the sur-
vival is based on the entire matching Swedish popula-
tion. No statistical comparison between the curves was
performed.
Results
Acute phase
Sixty-six patients were included in the study. Although
patients deemed to be in need of acute aortic repair
were excluded, other complications during the acute
phase did not exclude patients. Two patients developed
neurological symptoms with sensory/motor deficit in
the right leg. Two patients developed stroke with right
sided hemiplegia. One of these recovered completely
and the other had a slight remaining paresis. Two pa-
tients developed signs of ischemia in the right leg.
One of them recovered spontaneously and the other af-
ter acute embolectomy. In one patient, suspected acute
bowel ischemia was ruled out by exploratory laparot-
omy. One patient underwent acute median sternotomy
on the suspicion of type A aortic dissection. The ascend-
ing aorta was found not to be involved in the dissection.
Twelve patients had an increase in serum creatinine to
>150 mmol/L without clinically apparent renal failure.
One patient with previously known renal failure
became dialysis dependent. One patient needed treat-
ment for sepsis and one was artificially ventilated due
to secondary pneumonia.
Follow-up
The mean duration of follow-up was 6.6 years or 79
months (range 22e179 months). Fifty patients out of
the sixty-six were alive at the conclusion of the study.
Seven patients died of causes unrelated to their aorta(cancer and stroke) and nine patients (14%) died from
causes related to aortic disease (aortic rupture and
new type A aortic dissection) further described below.
The actuarial survival rate was 100% at 1 year, 82% at
five years and 69% at 10 years, with a survival curve
resembling the survival curve for the age and gender
matched Swedish population (Fig. 1). Eighty-five per-
cent of the patients remained free from dissection-
related death at 5 years and 82% at 10 years (Fig. 2).
Two patients were censored after 29 and 33 months
follow-up due to out of area relocation and 1 patient
declined further follow-up after 50 months.
Ten patients of 66 (15%) developed aneurysm
(>6.0 cm) of the dissected aorta. Of these, 2 patients
underwent elective aneurysm resection. Three of the
10 patients died from rupture of chronic type B dissec-
tion. Operation had been advised in two of these pa-
tients: One of them died suddenly a few days before
admission to hospital for surgery of a descending
aortic aneurysm and one who had been scheduled
for abdominal aortic aneurysm surgery suffered rup-
ture and died during emergency repair. The third
death from rupture occurred in a 73 year old patient.
He was one of 6 patients who met indications for
surgery but had contraindications or declined surgery.
Fifty-six patients did not exceed 6 cm in aortic
diameter during follow-up. One of them died from
rupture of chronic type B dissection and one died sud-
denly for an unknown cause. One patient was treated
with endovascular stent-graft placement because
of a saccular outpouching of an area of localized
dissection in an intramural hematoma. Five patients
sustained a new type A aortic dissection during
follow-up. One of them was successfully operated, 1
0
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Fig. 1. Actuarial survival percentages for 66 patients
followed after acute type B aortic dissection. The survival
percentage for the entire age- and gender-matched Swedish
population for each year of follow-up is plotted for compar-
ison. Numbers above X-axis show patients at risk left in
follow-up.Eur J Vasc Endovasc Surg Vol 32, October 2006
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were found on autopsy.
Overall, the mean value of the maximal diameter of
the dissected aorta was 4.3 0.8 cm during the acute
phase compared to a mean of 4.7 1.3 cm at the last
CT-scan (P< 0.01) irrespective of length of follow-
up. In 54 (82%) of the patients the aorta dilated 1 cm
or less during follow-up and in 9 (14%) the aorta di-
lated 2 cm or more during follow-up. Thirty-nine pa-
tients (59%) had a maximal diameter of the dissected
aorta of less than 5.0 cm. The mean value of maximal
aortic diameter for each year of follow-up is illus-
trated in Fig. 3. The overall mean yearly change in
aortic diameter was 1 2.4 mm/year.
Between the three identified subtypes of dissection
there was no difference in size during the acute phase,
but patients with ‘‘pure’’ intramural hematoma had
a smaller maximal aortic diameter at last CT scan
(3.8 0.7 cm) compared to patients with double barrel
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Fig. 2. Actuarial freedom from dissection-related death and
from aortic event in patients followed up after acute type B
aortic dissection. The study begins after the patient has sur-
vived acute type B dissection without surgical intervention.
Numbers above X-axis show patients at risk.
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Fig. 3. The mean (SD) maximal diameter of the dissected
aorta for each year of follow-up. Numbers above the X-
axis show number of patients available for analysis.Eur J Vasc Endovasc Surg Vol 32, October 2006dissection (5.1 1.2, P< 0.001) and patients with
intramural hematoma with localized dissection
(4.5 1.5 cm, ns). The mean yearly change in aortic
diameter was in ‘‘pure’’ intramural hematoma
0.4 1.1 mm/year compared to 1.4 2.7 (P< 0.01)
and 1.2 2.0 (P< 0.05) for the other two subgroups.
The freedom from dissection-related death in the
three subgroups was for double barrel dissection
82% at 5, 8 and 12 years, for ‘‘pure’’ intramural hema-
toma 100% at 5 and 8 years and for intramural hema-
toma with localized dissection 80% at 5 years and 40%
at 8 years (with only 2 patients left in follow-up).
New morbidity during follow-up
A 30 year old woman had acute onset of permanent
paraplegia after 6 months. No changes in CT-appearance
of the dissection were found. Four patients developed
claudication and were referred to vascular surgeons
for evaluation. Three patients had onset of angina pecto-
ris. One of them underwent coronary artery bypass
surgery. One patient had onset of diabetes mellitus.
Aortic events
Eighteen patients experienced ‘‘aortic event’’ during
follow-up (Fig. 4) divided between 11 patients with
‘‘double barrel dissection and 7 patients with intra-
mural hematoma with localized dissection/ulcer-like
projection. Actuarial event-free rates were 75% at 5
years and 67% at 10 years (Fig. 2).
Univariate analysis was performed regarding possi-
ble predictors of aortic event, comparing patients with
uneventful follow-up with patients who had ‘‘aortic
event’’ (Table 2). The aortic event group included a sig-
nificantly larger number of patients with a diameter
>4.0 cm at time of acute dissection and/or intramural
hematoma with localized dissection/ulcer-like projec-
tion. No patients with ‘‘pure’’ intramural hematoma
experienced an aortic event during follow-up.
Multivariable Cox proportional hazards analysis
revealed intramural hematoma with localized dissec-
tion/ulcer-like projection (hazard ratio 4.5, 95% confi-
dence level 1.8 to 13.1; P¼ 0.0018) and a maximal
diameter of >4.0 cm at first CT-scan (hazard ratio
3.5, 95% confidence level 1.2 to 9.7, P¼ 0.0184) to be
significant predictors of aortic event.
Discussion
Our study was initiated in 1990 when we started an
out-patient clinic for patients with aortic disease.
The aim of the study was to create a base of
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Fig. 4. Outcome in 66 patients prospectively followed after conservative treatment of acute type B aortic dissection. Three
different subtypes of dissection were identified during the course of the study. Aortic events include dissection related
death, rupture, new type A aortic dissection, and aneurysm formation (>6.0 cm in maximal diameter).knowledge and to investigate the long term result of
conservative treatment of acute type B aortic dissec-
tion. At the time there were no prospective long-
term studies for this patient category.
Table 2. Twelve variables used to seek for predictors of aortic
event (dissection related death, rupture, new type A aortic dissec-
tion, aneurysm formation) during the chronic phase of type B aor-
tic dissection after conservative management during the acute
care. Patients that experienced aortic event are compared to
patients with an uneventful follow-up for each variable using
log rank test. A P< 0.05 is considered statistically significant
Variables Aortic event
(n¼ 18)
Uneventful
follow-up
(n¼ 48)
P Value
(log rank test)
Gender: Male 14 36 1.0
70 years of age 4 15 1.0
Smoking 10 27 1.0
Hypertension 6 28 0.76
History of
cardio-vascular disease
4 8 0.72
Extent of dissection:
Below diaphragm
13 39 0.20
Regular ‘‘double
barrel’’ dissection
11 29 0.92
‘‘Pure’’ Intramural
hematoma
0 14 0.02
Intramural hematoma
with localized
dissection/ulcer-like
projection
7 5 0.005
Max diam> 4.0 cm
at first CT scan (acute)
12 16 0.02
Creatinine> 150 mmol/L 3 10 0.94
Poor blood pressure
control during follow-up
5 9 0.5We have over the years adhered to the conservative
approach for the treatment of acute type B aortic dis-
section. Our approach to surgical treatment of aortic
dilatation of chronic type B dissection is also generally
conservative. Patients are usually considered for sur-
gery when the aorta has reached a diameter of more
than 6.0 cm. In this somewhat elderly population
patients often have contraindications for surgery or
simply decline surgery.
A strength of our study is its prospective design. All
patients have been followed closely, making possible
accurate assessment of the endpoints reached. There
was a very low drop-out rate (2 patients due to reloca-
tion and 1 patient declining further follow-up).
A weakness of the study is that no figures can be
given for total mortality caused by acute type B dis-
section in our area. The study is designed as a prospec-
tive follow-up of patients referred from the entire
Stockholm area and the ‘‘true’’ mortality and total ini-
tial outcome is not known. There is a selection in that
the patients studied are all the patients referred to our
institution and not all patients with type B dissection.
The disease is a great masquerader, and many poten-
tial patients may have been missed because of an in-
correct diagnosis or because they died early. In some
patients the dissection was diagnosed late and the pa-
tient was already in the chronic phase when referred.
Our study with close follow-up, shows that patients
do well during the chronic phase after surviving con-
servative treatment of acute type B dissection: overEur J Vasc Endovasc Surg Vol 32, October 2006
354 A. Winnerkvist et al.80% of the patients remained free from dissection-
related death after 10 years. The total survival resem-
bles the survival curve for the age and sex-matched
Swedish population. In a separate study we have also
shown that our patients quality of life in terms of func-
tioning and wellbeing differ little from a normative
Swedish population.16 The results of our follow-up
confirm the positive prognosis reported in some earlier
retrospective studies.17e19 The more dismal prognosis
reported by the Stanford group5 may not be so bad if
one takes into account that the patient population is
elderly. In fact, after initial mortality is subtracted, the
Stanford patients given medical treatment seems to
have a survival resembling the observed survival in
an age and gender matched US population.
The incidences of aneurysm formation and aortic
rupture in our study are relatively low, with 15% of
patients reaching a maximal aortic size of >6.0 cm in
diameter and 7.5% of patients dying from rupture of
chronic dissection. The ruptures came after a mean of
3.9 years of follow-up (1.1 years, SD). Since the
incidences of rupture and aneurysm formation were
relatively low, ‘‘negative’’ outcomes were grouped to-
gether as ‘‘aortic event’’ for statistical comparison.
This was performed similarly to the study by
Onitsuka et al.18 An initial aortic diameter of >4.0 cm
and the variant of intramural hematoma with areas of
localized dissection or ulcer-like projections turned
out to be significant multivariate predictors of aortic
event.
During the course of this study the resolution of di-
agnostic imaging e.g. CT-scanning, has improved tre-
mendously and subtypes of dissection have become
evident. The European society of Cardiology (The
Task Force on Aortic Dissection), published in 2001
a reclassification of aortic dissection.20 The subtypes
of dissection are discussed in the literature, but the
nomenclature varies between authors. In our patients
we identified three subtypes. 1. The classical picture
of dissection has a ‘‘double barrel’’ appearance on
CT-scan with a dissection flap and flow in the false
lumen with or without partial thrombosis. 2. The var-
iant of acute aortic dissection described as intramural
hematoma.21 Intramural hematoma is characterized
by a regional aortic wall thickening, circular or cres-
cent shaped, with evidence of intramural accumula-
tion of blood and no detectable intimal tear. 3. In
some cases the intramural hematoma had areas with
localized dissection or contrast filled pouches in the
aortic wall. Similar changes with the common finding
of a localized intimal defect are in some papers
termed aortic ulcer or ulcer-like projection.
One of our study’s main findings is that ‘‘pure’’
intramural hematoma in the thoracoabdominal aortaEur J Vasc Endovasc Surg Vol 32, October 2006has an excellent prognosis: none of these patients
experienced an aortic event during follow-up. The
aortic wall ‘‘healed’’ within 6e12 months leaving
only a slight thickening of the wall visible on CT-
scan. The patients with intramural hematoma and
localized dissection or ulcer-like projection seem to
have a different prognosis, with an increased risk of
‘‘aortic event’’ during follow-up. One might speculate
that the intimal defect makes the aorta susceptible to
dilatation or subsequent dissection.
In all the patients with double barrel dissection the
false lumen remained patent with a varying grade of
thrombosis throughout follow-up. Patients with dou-
ble-barrel dissection had an actuarial freedom from
dissection-related death and aortic event rate similar
to the entire patient group.
The aortic diameter seems to be important for the
risk of aortic rupture. This is clearly demonstrated
in patients where the type B dissection was of the
double barrel variety. Eight of the 40 patients with
double barrel dissection (20%) developed aneurysm
(>6.0 cm). Three patients of these 8 (37%) suffered
an aortic rupture during follow-up but only 1/32
(3%) of the patients without aneurysm formation suf-
fered a rupture (P< 0.05).
Another interesting finding is that 5 patients (7.5%)
developed an acute type A dissection during follow-
up. This occurred a mean of 4.6 years (1.6 years
SD) after the type B dissection. In four of these 5 pa-
tients the new dissection was fatal. In none of these
patients did the maximal aortic diameter exceed
6.0 cm. In 2 of the patients the type B dissection was
of the double barrel variety and in the remaining 3 pa-
tients of the variety with intramural hematoma and
localized dissection. We could not determine if the
type A dissection originated from a ‘‘new’’ intimal
tear in the ascending aorta or if it was due to retro-
grade progression from the previous dissection.
In conclusion, patients with chronic aortic dissec-
tion have a survival resembling that of the normal
population. The relatively low rate of aneurysm
formation and low incidence of aortic rupture in addi-
tion to data showing a good quality of life16 supports
the strategy of reserving surgical intervention for
complications of acute type B dissection. For treating
complications, endovascular stent-graft placement
has been proven a suitable alternative to open surgery.
However, before prophylactic stent-grafting can be
considered as the preferred treatment modality for
most patients with acute type B aortic dissection, the
results of conservative treatment must be matched
or improved upon. The stent-grafting procedure
itself is not totally risk free and can cause acute com-
plications such as acute embolic stroke or extended
355Follow-up of Type B Aortic Dissectiondissection into the arch and ascending aorta.22e24 The
stent-grafts may develop problems over time such as
endoleaks, endopressure and structural failures.25,26
These problems still need to be solved.
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